Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Aug 28, 2022 1:40pm
177 Views
Post# 34925382

RE:No volume and no liquidity

RE:No volume and no liquidity

Releasing a few million shares on the sell side will do nothing except create downward pricing pressure. 

Needs wider promotion and coverage at the same time, in order to create demand & volume ...

Easily done given count down to FDA, BTD, recent SAMI sales, involvement of major players, Trial results, and ongoing paradigm shift to HHD... but..,then again...

... shining a light on the story has never been part of the program. 


MM 

<< Previous
Bullboard Posts
Next >>